Why is Venmax Drugs falling/rising?

As of 24-Sep, Venmax Drugs & Pharmaceuticals Ltd is currently priced at 23.91, reflecting a slight increase of 0.06 or 0.25%. The stock has shown a trend reversal, gaining after two consecutive days of decline. Despite this recent uptick, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Additionally, the stock has outperformed its sector by 0.7% today, and there has been a notable increase in investor participation, with delivery volume rising by 61.39% compared to the 5-day average. However, there are no available positive or negative factors to further elucidate the reasons behind the stock's recent movement.
Broader Market Context: In the short term, Venmax Drugs has underperformed the benchmark Sensex, with a 1-week return of -0.58% compared to the Sensex's -1.18%. Over the past month, the stock has seen a significant decline of 24.34%, while the Sensex has gained 0.50%. Year-to-date, Venmax Drugs has performed well with a return of 32.54%, significantly outpacing the Sensex's 4.58%. This contrast highlights the stock's volatility and the challenges it faces in the current market environment, despite its strong year-to-date performance.